NL-OMON28223招募中不适用
Anakinra versus treatment as usual in the treatment of acute gout
prof. dr. M.A.F.J. van de Laar0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •At least 18 years of age
- •Signed written informed consent.
排除标准
- •Absolute contra-indication for all available types of ULT (allopurinol, febuxostat and benzbromaron)
- •Absolute contra-indication for anakinra (i.a. creatinine clearance rate < 30 ml/ minute
研究者
相似试验
进行中（未招募）
1 期
Anakinra versus treatment as usual in the treatment of acute goutGoutEUCTR2015-000696-27-NLprof. dr. M.A.F.J. van de Laar200
已完成
不适用
Anakinra versus treatment as usual in the treatment of acute goutNL-OMON47178niversiteit Twente (prof. dr. M.A.F.J. van de Laar)200
进行中（未招募）
1 期
Efficacy and safety of anakinra (antagonist of the interleukin-1 receptor) in the treatment of periarticular inflammation in patients refractory to NSAID and / or steroidsInflammation in periarticular structures in patients refractory to NSAIDs and / or corticosteroids.EUCTR2013-005402-65-ESInstitut de Recerca HSCSP20
进行中（未招募）
不适用
Treatment with Anakinra in TRAPS - NDMedDRA version: 9.1Level: LLTClassification code 10016202Term: Familial amyloidosisTRAPSEUCTR2006-001927-20-ITISTITUTO GIANNINA GASLINI
进行中（未招募）
不适用
Efficacy and safety of treatment with Anakinra in patients with CINCA/MUCKLE-WELLS syndrome and systemic juvenile idiopathic arthritisEUCTR2005-004008-36-ITISTITUTO GIANNINA GASLINI